ProMIS Neurosciences EPS
What is the EPS of ProMIS Neurosciences?
The EPS of ProMIS Neurosciences, Inc. is -0.02
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on OTC compared to ProMIS Neurosciences
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Companies with eps similar to ProMIS Neurosciences
- China Fordoo has EPS of -0.02
- The Supreme Cannabis Co has EPS of -0.02
- Peijia Med Ltd has EPS of -0.02
- Milan Station has EPS of -0.02
- Imperial Metals has EPS of -0.02
- Newcastle has EPS of -0.02
- ProMIS Neurosciences has EPS of -0.02
- Platina Resources has EPS of -0.02
- Lvji Technology Inc has EPS of -0.02
- good natured Products has EPS of -0.02
- Wan Leader International has EPS of -0.02
- Sarama Resources Ltd has EPS of -0.02
- Grand Ming has EPS of -0.02